I'm keeping a close eye on CoreWeave, Inc. (CRWV) as it reports first quarter 2026 earnings after market close today, May 7. As a leading AI cloud infrastructure provider, the company is at the heart of the explosive demand for GPU-powered computing driven by the AI boom. With Nvidia GPUs central to its platform, CoreWeave supports enterprises developing large language models and AI applications. Recent quarters have delivered revenue growth tripling year-over-year, yet mounting losses from capital expenditures and debt interest continue to raise questions about the path to profitability. From what I see, investors will look to this report for confirmation on converting that impressive $66.8 billion backlog into revenue and expanding capacity to 3.1 GW of contracted power. In a competitive AI sector, these results could indicate whether hyperscaler growth remains sustainable.
Wall Street's consensus points to $1.96 billion in revenue for the quarter ended March 31, 2026, representing roughly 100% growth from $981.6 million in Q1 2025. This fits squarely with management's guidance of $1.9-$2.0 billion, provided after Q4 results. The EPS consensus is -$1.20, drawn from 14 analysts, marking a wider loss than last year's -$0.60 due to escalating investments.
Key metrics to watch include Adjusted EBITDA margins, which reached 57% in Q4 2025, and power capacity utilization. In Q4 2025, revenue beat estimates at $1.57 billion against $1.55 billion expected, but EPS missed at -$0.89 versus -$0.61, leading to an 18% stock drop on capex worries. Q1 2025 brought 420% revenue growth to $982 million, though the net loss expanded to $315 million. Over the past four quarters, the stock has averaged a -14.5% reaction post-earnings, highlighting the volatility often linked to guidance updates.
Heading into earnings, CRWV shares climbed 7.89% to $137.98 on May 6, buoyed by optimism around AI tailwinds and year-to-date gains exceeding 92%. Options pricing suggests an 11-18% move after the report. Sentiment leans bullish on revenue potential but remains cautious about losses; previous misses, such as in Q4, prompted sharp selloffs even with a strong backlog. Key risks involve capex overruns, rising debt at $21 billion by Q4's end, and potential GPU supply constraints. With 28 analysts covering the stock, price targets cluster around $131-$160.
In my analysis, I also checked this using Tickeron’s AI Screener, which helps me filter stocks and ETFs based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of assets with customizable filters like industry, market cap, technical indicators, price patterns, and performance metrics, surfacing trade ideas, trending stocks, breakouts, and opportunities far more efficiently than manual methods. I find it particularly useful for spotting potential plays in the AI infrastructure space like CRWV.
After Q1 results, attention will turn to updated FY 2026 guidance, where consensus forecasts $12.49 billion in revenue, a 143% increase from 2025's $5.13 billion. The backlog conversion rate becomes especially critical, with $66.8 billion in visibility underpinning multi-year growth.
One thing that stands out is the need to track active power capacity additions beyond 850 MW and the contracted 3.1 GW, as data center expansions could push annual capex to $30-35 billion. Margin pressures persist from interest expenses, which hit $388 million in Q4, and GPU costs, though Adjusted EBITDA expansion points to emerging operational leverage.
Looking ahead, catalysts include Q2 capacity ramps, fresh hyperscaler contracts, and Nvidia Blackwell GPU deployments. Broader AI demand, supply chain reliability, and debt management will influence the trajectory. I’m watching industry peers closely for signs of competitive pricing shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The 10-day RSI Indicator for CRWV moved out of overbought territory on May 07, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 instances where the indicator moved out of the overbought zone. In of the 8 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on May 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRWV as a result. In of 14 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CRWV turned negative on May 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRWV broke above its upper Bollinger Band on May 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
CRWV moved above its 50-day moving average on April 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CRWV crossed bullishly above the 50-day moving average on April 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in of 62 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 55 cases where CRWV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRWV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.755) is normal, around the industry mean (14.329). P/E Ratio (0.000) is within average values for comparable stocks, (124.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.553). CRWV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (9.033) is also within normal values, averaging (163.493).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows